Latest News & Features
Americas
The US Food and Drug Administration has released a final rule to reduce unnecessary litigation between brand owners and generic drugs producers. 12 October 2016
Asia
India-based Piramal Enterprises has signed an agreement with Belgian pharmaceutical company Janssen under which Piramal will acquire five anaesthesia and pain management products for $155 million in cash. 12 October 2016
Americas
Mylan has agreed to pay the US Department of Justice and other government agencies $465 million to settle questions about the classification of EpiPen Auto-Injector under the Medicaid Drug Rebate Program. 11 October 2016
Americas
Pfizer has agreed to sell its infusion therapy business to US medical manufacturer ICU Medical for $1 billion. 11 October 2016
Americas
Ireland-based biopharmaceutical company Mallinckrodt and Endo, a US healthcare business, have won a patent case against Amneal and Teva. 10 October 2016
Africa
AstraZeneca and Cilag, an affiliate of Johnson & Johnson, have entered into an agreement for AstraZeneca to divest the rights to Rhinocort Aqua outside the US. 10 October 2016
Americas
Teva and South Korean biopharmaceutical company Celltrion have entered into an exclusive partnership to commercialise two of Celltrion’s biosimilars in the US and Canada. 7 October 2016
Americas
Hedge fund manager Kyle Bass has lost a patent case against Shire over the drug Lialda. 7 October 2016
Americas
Amgen has filed complaints against Indian pharmaceutical companies Dr Reddy’s and Ajanta Pharma for allegedly infringing a patent centring on its drug Sensipar. 6 October 2016
Big Pharma
Teva has agreed to sell certain assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals. 6 October 2016